[{"address1": "200 Minuteman Road", "address2": "Suite 302", "city": "Andover", "state": "MA", "zip": "01810", "country": "United States", "phone": "978 552 0900", "website": "https://www.transmedics.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.", "fullTimeEmployees": 584, "companyOfficers": [{"maxAge": 1, "name": "Dr. Waleed H. Hassanein M.D.", "age": 55, "title": "Founder, President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1817496, "exercisedValue": 13381959, "unexercisedValue": 45252580}, {"maxAge": 1, "name": "Mr. Stephen  Gordon", "age": 55, "title": "CFO, Treasurer & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 909615, "exercisedValue": 1305500, "unexercisedValue": 3853568}, {"maxAge": 1, "name": "Mr. Nicholas  Corcoran", "age": 40, "title": "Senior Vice President of Supply Chain & Operations", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 812071, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anil  Ranganath", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "totalPay": 561674, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamer I. Khayal M.D.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 900108, "exercisedValue": 5450721, "unexercisedValue": 5052497}, {"maxAge": 1, "name": "Ms. Miriam C. Provost Ph.D.", "age": 62, "title": "Vice President of Global Regulatory Affairs", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 535930, "exercisedValue": 390248, "unexercisedValue": 1664774}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 81.97, "open": 82.62, "dayLow": 80.885, "dayHigh": 85.466, "regularMarketPreviousClose": 81.97, "regularMarketOpen": 82.62, "regularMarketDayLow": 80.885, "regularMarketDayHigh": 85.466, "beta": 1.986, "trailingPE": 88.60215, "forwardPE": 49.939396, "volume": 1816742, "regularMarketVolume": 1816742, "averageVolume": 1365739, "averageVolume10days": 3125840, "averageDailyVolume10Day": 3125840, "bid": 82.23, "ask": 82.47, "bidSize": 100, "askSize": 100, "marketCap": 2765467648, "fiftyTwoWeekLow": 40.01, "fiftyTwoWeekHigh": 177.37, "priceToSalesTrailing12Months": 6.894881, "fiftyDayAverage": 140.6626, "twoHundredDayAverage": 122.3498, "currency": "USD", "enterpriseValue": 2953520896, "profitMargins": 0.08137, "floatShares": 32545274, "sharesOutstanding": 33561500, "sharesShort": 6439780, "sharesShortPriorMonth": 5497500, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.1919, "heldPercentInsiders": 0.031770002, "heldPercentInstitutions": 1.07016, "shortRatio": 5.0, "shortPercentOfFloat": 0.2334, "bookValue": 6.255, "priceToBook": 13.173461, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": 32638000, "trailingEps": 0.93, "forwardEps": 1.65, "enterpriseToRevenue": 7.364, "enterpriseToEbitda": 57.756, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TMDX", "underlyingSymbol": "TMDX", "shortName": "TransMedics Group, Inc.", "longName": "TransMedics Group, Inc.", "firstTradeDateEpochUtc": 1556803800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "92140e2a-40a2-3a8f-af5f-f1195b90106c", "gmtOffSetMilliseconds": -18000000, "currentPrice": 82.4, "targetHighPrice": 180.0, "targetLowPrice": 87.0, "targetMeanPrice": 139.25, "targetMedianPrice": 137.5, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 330094016, "totalCashPerShare": 9.835, "ebitda": 51138000, "totalDebt": 518145984, "quickRatio": 6.998, "currentRatio": 8.201, "totalRevenue": 401089984, "debtToEquity": 246.83, "revenuePerShare": 12.157, "returnOnAssets": 0.02836, "returnOnEquity": 0.19405001, "freeCashflow": -142587504, "operatingCashflow": 37444000, "revenueGrowth": 0.637, "grossMargins": 0.59336, "ebitdaMargins": 0.1275, "operatingMargins": 0.03607, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-04"}]